Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease.
暂无分享,去创建一个
[1] Xin Yu,et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.
[2] C R Jack. Brain and cerebrospinal fluid volume: measurement with MR imaging. , 1991, Radiology.
[3] Bruce L. Miller,et al. Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology , 2007 .
[4] G. Frisoni,et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.
[5] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[6] J. Morris,et al. Validation of clinical diagnostic criteria for Alzheimer's disease , 1988, Annals of neurology.
[7] A. Toga,et al. Hippocampal Atrophy in Persons With Age-Associated Memory Impairment: Volumetry Within a Common Space , 2002, Psychosomatic medicine.
[8] H Soltanian-Zadeh,et al. Segmentation of the hippocampus from brain MRI using deformable contours. , 1998, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[9] M N Rossor,et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.
[10] Henry Rusinek,et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. , 2003, Radiology.
[11] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[12] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[13] G. Frisoni,et al. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[14] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[15] N. Schuff,et al. Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia , 2002, Journal of magnetic resonance imaging : JMRI.
[16] J V Hajnal,et al. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. , 2002, The British journal of radiology.
[17] Michael I. Miller,et al. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging☆ , 2003, NeuroImage.
[18] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[19] Vladimir Kepe,et al. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology , 2006, Current opinion in psychiatry.
[20] Nick C. Fox,et al. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.
[21] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[22] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[23] Paul M. Thompson,et al. In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study , 2006, NeuroImage.
[24] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Schuff,et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia , 2003, Neurobiology of Aging.
[26] Nick C Fox,et al. Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease , 2005, Neurology.
[27] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[28] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[29] Alan C. Evans,et al. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls , 2008, Neurobiology of Aging.
[30] C. Jack,et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.
[31] C. Jack,et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD , 2003, Neurology.
[32] Gwenn S. Smith,et al. EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.
[33] Hiroko H Dodge,et al. Functional transitions and active life expectancy associated with Alzheimer disease. , 2003, Archives of neurology.
[34] M. Albert,et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.
[35] S. Wisniewski,et al. Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II , 2000, Neurology.
[36] Paul M. Thompson,et al. Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.
[37] Nick C Fox,et al. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. , 1998, Journal of computer assisted tomography.
[38] R. Mayeux. Evaluation and Use of Diagnostic Tests in Alzheimer’s Disease , 1998, Neurobiology of Aging.
[39] S Lehéricy,et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.
[40] Nick C Fox,et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.
[41] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[42] Nick C Fox,et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. , 2005, Archives of neurology.
[43] Richard Camicioli,et al. Independent predictors of cognitive decline in healthy elderly persons. , 2002, Archives of neurology.
[44] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[45] J. Quinn,et al. Changes in premorbid brain volume predict Alzheimer’s disease pathology , 2003, Neurology.
[46] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[47] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[48] Hiroaki Kazui,et al. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? , 2005, The American journal of psychiatry.
[49] Frederik Barkhof,et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.
[50] J. Masdeu,et al. Neuroimaging as a marker of the onset and progression of Alzheimer's disease , 2005, Journal of the Neurological Sciences.
[51] Gene E. Alexander,et al. Volumes of Medial Temporal Lobe Structures in Patients with Alzheimer’s Disease and Mild Cognitive Impairment (and in Healthy Controls) , 1998, Biological Psychiatry.
[52] Lei Wang,et al. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. , 2005, Archives of neurology.
[53] Alain Pitiot,et al. Expert knowledge-guided segmentation system for brain MRI , 2003, NeuroImage.
[54] Antonio Federico,et al. Cerebrospinal fluid tau, Aß, and phosphorylated tau protein for the diagnosis of Alzheimer's disease , 2006, Journal of cellular physiology.
[55] W R Markesbery,et al. An automated technique for measuring hippocampal volumes from MR imaging studies. , 2001, AJNR. American journal of neuroradiology.
[56] A. Hofman,et al. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. , 2006, Archives of general psychiatry.
[57] M N Rossor,et al. Measuring atrophy in Alzheimer disease , 2005, Neurology.
[58] Randall S. Jones,et al. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia , 2004, Neurological research.
[59] V. Hachinski,et al. A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.
[60] Nick C Fox,et al. Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial , 2005, Neurology.
[61] Tuomo Hänninen,et al. Diagnosis of Alzheimer’s disease: MRI of the hippocampus vs delayed recall , 2000, Neuropsychologia.
[62] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[63] Hilkka Soininen,et al. Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study , 2000, Biological Psychiatry.
[64] Kiralee M. Hayashi,et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.
[65] J. Baron,et al. In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.
[66] C. Jack,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.
[67] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[68] N. Schuff,et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[69] Jeffrey L. Cummings,et al. Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[70] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[71] Martin Rossor,et al. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. , 2006, Archives of neurology.
[72] S. Joshi,et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus , 2000, Neurology.
[73] N. Schuff,et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD , 2004, Neurology.
[74] J. Kaye,et al. Asynchronous regional brain volume losses in presymptomatic to moderate AD. , 2005, Journal of Alzheimer's disease : JAD.
[75] H. Braak,et al. Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.
[76] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[77] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.